Article Information
- Received October 30, 2020
- Revision received April 13, 2021
- Accepted April 15, 2021
- First published April 23, 2021.
- Version of record published June 2, 2021.
Author Information
- Silas A. Buck1,2,*,
- Briana R. De Miranda3,4,*,
- Ryan W. Logan5,6,
- Kenneth N. Fish2,
- J. Timothy Greenamyre3,7, and
- Zachary Freyberg2,8
- 1Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213
- 2Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213
- 3Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260
- 4Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, 35294
- 5Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, 02118
- 6Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, Maine, 04609
- 7Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260
- 8Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213
Author contributions
Author contributions: S.A.B., B.R.D.M., K.N.F., J.T.G., and Z.F. designed research; S.A.B., B.R.D.M., and K.N.F. performed research; S.A.B., B.R.D.M., R.W.L., K.N.F., and Z.F. analyzed data; S.A.B., B.R.D.M., and Z.F. wrote the first draft of the paper; S.A.B., B.R.D.M., R.W.L., K.N.F., J.T.G., and Z.F. edited the paper; S.A.B., B.R.D.M., J.T.G., and Z.F. wrote the paper; K.N.F. contributed unpublished reagents/analytic tools.
↵*S.A.B. and B.R.D.M. contributed equally to this work.
Disclosures
- Received October 30, 2020.
- Revision received April 13, 2021.
- Accepted April 15, 2021.
This work was supported in part by National Institutes of Health Grant R21AG068607 to Z.F. and Grant K99ES029986 to B.R.D.M., the John F. and Nancy A. Emmerling Fund of the Pittsburgh Foundation to Z.F., and the American Parkinson Disease Association Center for Advanced Research at the University of Pittsburgh to J.T.G. We thank Drs. Thomas Hnasko and Thomas Steinkellner for helpful discussions.
The authors declare no competing financial interests.
- Correspondence should be addressed to Zachary Freyberg at freyberg{at}pitt.edu
Funding
NIH/NIA
R21AG068607NIH/NIEHS
K99ES029986John F. and Nancy A. Emmerling Fund of The Pittsburgh Foundation
American Parkinson Disease Association Center for Advanced Research at the University of Pittsburgh
Other Version
- previous version (April 23, 2021).
- You are viewing the most recent version of this article.
Online Impact
